课题基金 / 基金详情

IL-21 polymorphisms in systemic lupus erythematosus

IL-21 polymorphisms in systemic lupus erythematosus
系统性红斑狼疮中IL-21多态性
批准号:
7642427
负责人:
Amr H Sawalha
金额:
$6.3万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-20 至 2011-05-31

项目摘要

项目成果

Amr H Sawalha的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Evidence indicates that SLE is polygenic, and it has been speculated that individual mutated genes may contribute to specific features of the disease. IL-21 is a type I cytokine that plays important roles in the differentiation of B cells into plasma cells, in dendritic cell maturation, and in T cell responses. IL-21 is therefore an attractive candidate gene for SLE. Preliminary studies strongly suggest that IL-21 is polymorphic in patients with SLE. The hypothesis to test is that IL-21 polymorphisms are associated with functional consequences that increase the susceptibility to SLE. Two specific aims are proposed: 1) characterize the polymorphisms and haplotypes of IL-21 that cause SLE susceptibility, and 2) determine the functional consequences of IL-21 polymorphisms upon SLE susceptibility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing the Takayasu arteritis genetic risk in RPS9/LILRB3
Characterizing the Takayasu Arteritis Genetic Risk in RPS9/LILRB3
Role of DNA methylation in lupus
Role of DNA methylation in lupus
海外基金